The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to diagnose and treat HIV.

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

National Aids Commission (NAC) and health campaigners have welcomed the approval of a twice-a-year HIV prevention injection ...

Oil prices jumped on Monday to their highest since January as the United States' weekend move to join Israel in attacking ...

Researchers are waiting to see if a review by Health Canada will update guidance for mothers living with HIV who wish to ...

THE University of Zimbabwe Clinical Trials Research Centre (UZ-CTRC) is continuing research into finding a cure for HIV as the country seeks to ensure the chronic disease ceases to be a public health ...

The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...

The University of Zimbabwe Clinical Trials Research Centre (UZ-CTRC) is intensifying its efforts to find a cure for HIV, as ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of preventive management than in the general population. Last year, an HHS panel ...